Mednet Logo
HomePrimary Care
Primary Care

Primary Care

Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.

Recent Discussions

What is your approach to establishing a dry weight in a pregnant patient with ESKD on hemodialysis given the expectation of weight increase and pregnancy-related edema?

2 Answers

Mednet Member
Mednet Member
Nephrology · Ohio State Department Of Nephrology

I think there is a lot of nuance managing weight in pregnant patients with ESRD. Pregnant patients have better fetal and maternal outcomes when clearance is increased. Outcomes are best with >36 hours of dialysis per week. Adjustment of dry weight should include assessment of volume status, blood pr...

When transitioning from anabolic agent to denosumab, do you stop teriparatide 1 day prior to transition and romosozumab 1 month prior to transition?

1 Answers

Mednet Member
Mednet Member
Rheumatology · U of AZ Phoenix Dept of Orthopaedics

I do not believe there is any comparison data to guide this question. My philosophy was to get denosumab going asap at the end of our scheduled anabolic course. I would often schedule a tptd or abaloparatide patient at 23 months to discuss denosumab and get the process started for approval. We often...

What range of musculoskeletal complaints have you seen with romosozumab use?

1 Answers

Mednet Member
Mednet Member
General Internal Medicine · University of New Mexico Health Sciences Center

The most common side effect with Romo is injection site reactions. Some patients may have musculoskeletal pain but so do many patients not on Romo. Overall, I found that it is very well tolerated, but if a patient believes that it is causing major undesirable effects, then it is probably best to sto...

How do you approach immunosuppression in patients with a positive Interferon Gamma Release Assay and prior intravesicular BCG treatment for bladder cancer?

3
1 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Bacillus Calmette–Guérin (BCG) is the most widely used vaccine worldwide and has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumor immune response, which urologists have harnessed for the treatment of non-muscle-invasive bladder cancer. As rheumatologists, we occasio...

What dosing range of oral minoxidil do you prescribe for patients with hair loss?

7
5 Answers

Mednet Member
Mednet Member
Dermatology · Forefront Dermatology

I have really enjoyed adding this to our AGA treatment algorithm. I like to start at half of the 2.5 mg tab for women daily and the full tab for men. I then increase at each follow-up based on the patient's tolerance for AEs (increased hair elsewhere, BP, edema, lightheadedness). I max out at 5 in w...

Is it sufficient to maintain patients with atrial fibrillation and established PAD on a DOAC or VKA alone, or is there an additional benefit to adding an antiplatelet agent for CVD benefit?

1 Answers

Mednet Member
Mednet Member
Cardiology · Yale University School of Medicine

If they have medically managed PAD with no recent intervention/revascularization, anticoagulation alone should be sufficient especially if their bleeding risk is not low. In general, most patients on anticoagulation for AF do not need to also be on anti-platelet agents for secondary prevention. Exc...

What’s your approach to recurrent “idiopathic” Erythema Nodosum that failed NSAIDs?

1 Answers

Mednet Member
Mednet Member
Dermatology · Case Western Reserve University

Next step in treatment would be SSKI with gradual dose titration upward to improve tolerance. For recurrent cases of EN, perform pharyngeal culture to look for strep.

Does vitamin D supplementation in primary hyperparathyroidism increase the risk of kidney stones?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

Hyperparathyroidism does increase the risk of developing kidney stones. A study in New England Journal of Medicine, Broadus et al., PMID 7351950, reported that patients with elevated concentrations of 1,25-dihydroxyvitamin D are at increased risk for kidney stones. The reason is that 1,25-dihydroxyv...

How do you determine when to transition off pegloticase to other uric acid lowering therapies?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · National institues of Health

When to transition patients off of pegloticase is a question that is frequently posed to me by my colleagues and by my patients. Pegloticase is not a drug meant for long-term therapy but rather to achieve specific targeted clinical outcomes. I usually recommend once those outcomes are achieved, that...

What additional testing is recommended with heterozygous HFE C282Y mutation whose ferritin is elevated and transferrin saturation percentage is at baseline?

2 Answers

Mednet Member
Mednet Member
Hematology · Rochester General Hospital

Here, both serum ferritin and transferrin saturation are significantly elevated. Assuming the patient is asymptomatic and LFTs are normal, this profile is suggestive of iron overload. I assume Hb is normal? Would do MRI to look for hepatic iron overload.